Abrazo Central Campus, 2000 W. Bethany Home Road, received an “A” grade in the latest hospital safety report card released in April by The Leapfrog Group.

The reports provide consumers with information they may find useful in making informed decisions about their healthcare. Grades reflect how hospitals perform on specific process and outcome measures assessed by Leapfrog, a nonprofit organization based in Washington, D.C.

Abrazo’s Central Campus was among 750 hospitals awarded an “A” for efforts in protecting patients and meeting high safety standards. Leapfrog Hospital Safety Grades are updated every spring and fall following assessments of more than 2,500 hospitals across the country.

Developed with the guidance of an expert panel, the peer-reviewed grades are based on 27 measures of publicly available hospital safety data.

In addition, stroke care provided at Abrazo Central Campus has been recognized with the American Heart Association/American Stroke Association’s Get With The Guidelines®-Stroke Gold Plus Quality Achievement Award and Target: Stroke Honor Roll award.

The Get With The Guidelines award acknowledges the hospital’s commitment to ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence.

To qualify for Target: Stroke Honor Roll award, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke.

According to the American Heart Association/American Stroke Association, stroke is the No. 5 cause of death and a leading cause of adult disability in the United States. On average, someone in the U.S. suffers a stroke every 40 seconds and nearly 795,000 people suffer a new or recurrent stroke each year.




Hello, North Central neighbor — thank you for visiting!

Sign up to receive our digital issue in your inbox each month.

We don’t spam! Read our privacy policy for more info.